These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24952194)

  • 1. Using breast milk to assess breast cancer risk: the role of mass spectrometry-based proteomics.
    Schneider SS; Aslebagh R; Ngounou Wetie AG; Sturgeon SR; Darie CC; Arcaro KF
    Adv Exp Med Biol; 2014; 806():399-408. PubMed ID: 24952194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics analysis of human breast milk to assess breast cancer risk.
    Aslebagh R; Channaveerappa D; Arcaro KF; Darie CC
    Electrophoresis; 2018 Feb; 39(4):653-665. PubMed ID: 29193311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial Electrophoresis and Mass Spectrometry-Based Proteomics in Breast Milk for Breast Cancer Biomarker Discovery.
    Aslebagh R; Channaveerappa D; Pentecost BT; Arcaro KF; Darie CC
    Adv Exp Med Biol; 2019; 1140():451-467. PubMed ID: 31347064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cancer-related proteins in paired breast milk samples from women with breast cancer.
    Arcaro KF; Browne EP; Qin W; Zhang K; Anderton DL; Sauter ER
    J Hum Lact; 2012 Nov; 28(4):543-6. PubMed ID: 22914689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical proteomics and breast cancer.
    Zeidan BA; Townsend PA; Garbis SD; Copson E; Cutress RI
    Surgeon; 2015 Oct; 13(5):271-8. PubMed ID: 25736469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic diagnosis competition: design, concepts, participants and first results.
    Mertens BJ
    J Proteomics; 2009 Jul; 72(5):785-90. PubMed ID: 19375529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
    Chung L; Baxter RC
    Expert Rev Proteomics; 2012 Dec; 9(6):599-614. PubMed ID: 23256671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target.
    Zeidan B; Jackson TR; Larkin SE; Cutress RI; Coulton GR; Ashton-Key M; Murray N; Packham G; Gorgoulis V; Garbis SD; Townsend PA
    Oncotarget; 2015 Aug; 6(25):21421-7. PubMed ID: 26093083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
    Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
    JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein biomarkers for subtyping breast cancer and implications for future research.
    Mueller C; Haymond A; Davis JB; Williams A; Espina V
    Expert Rev Proteomics; 2018 Feb; 15(2):131-152. PubMed ID: 29271260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis.
    Yang HP; Schneider SS; Chisholm CM; Browne EP; Mahmood S; Gierach GL; Lenington S; Anderton DL; Sherman ME; Arcaro KF
    Cancer Causes Control; 2015 Mar; 26(3):345-54. PubMed ID: 25604865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
    Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
    Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy.
    Browne EP; Punska EC; Lenington S; Otis CN; Anderton DL; Arcaro KF
    Epigenetics; 2011 Dec; 6(12):1425-35. PubMed ID: 22139572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry as a tool for biomarkers searching in gynecological oncology.
    Banach P; Suchy W; Dereziński P; Matysiak J; Kokot ZJ; Nowak-Markwitz E
    Biomed Pharmacother; 2017 Aug; 92():836-842. PubMed ID: 28601044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics in noninvasive breast cancer.
    Zhang AH; Sun H; Qiu S; Wang XJ
    Clin Chim Acta; 2013 Sep; 424():3-7. PubMed ID: 23669185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of aluminium content and iron homeostasis in nipple aspirate fluids from healthy women and breast cancer-affected patients.
    Mannello F; Tonti GA; Medda V; Simone P; Darbre PD
    J Appl Toxicol; 2011 Apr; 31(3):262-9. PubMed ID: 21337589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics Biomarkers for Breast Cancer.
    Günther UL
    Pathobiology; 2015 Sep; 82(3-4):153-65. PubMed ID: 26330356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.
    Journet A; Ferro M
    Mass Spectrom Rev; 2004; 23(6):393-442. PubMed ID: 15290709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.